Poniard Pharmaceuticals, a biopharmaceutical company, has appointed Greg Weaver as its new senior vice president and CFO.
Subscribe to our email newsletter
Mr Weaver is primarily responsible for management of the financial operations of the company. Most recently, Mr Weaver served as CFO of Talyst, a pharmacy automation healthcare IT company from 2007 to December 2008.
Mr Weaver is a certified public accountant and received his MBA in finance from Boston College and his BS in accounting from Trinity University.
Jerry McMahon, chairman and CEO of Poniard, said: “Greg has been a key executive in innovative and successful publicly traded healthcare companies, and has played a crucial role in increasing value for shareholders. His financial management experience will be invaluable as we move forward to complete enrollment in our pivotal phase III trial of picoplatin in small cell lung cancer and to develop strategic partnering and other opportunities to support our commercialization strategy.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.